Organic compounds -- part of the class 532-570 series patents - Monitor Patents Logo icons
Monitor Keywords Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents

USPTO Class 536  |  Browse by Industry: Previous - Next | All     monitor keywords
Recent  |  14: Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 13: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 12: Dec | Nov | Oct | Sep | Aug | July | June | May | April | Mar | Feb | Jan | 11: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan | 10: Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan |  | 09: Dec | Nov | Oct | Sep | Aug | Jl | Jn | May | Apr | Mar | Fb | Jn |  | 2008 | 2007 |

Organic compounds -- part of the class 532-570 series

Below are recently published patent applications awaiting approval from the USPTO. Recent week's RSS XML file available below.
Listing for abstract view: USPTO application #, Title, Abstract excerpt,Patent Agent. Listing format for list view: USPTO National Class full category number, title of the patent application.
09/04/2014 > 5 patent applications in 5 patent subcategories.

20140249301 - Methods for enabling farnesene accumulation in plants and related compositions: The invention provides novel methods and compositions directed to farnesol production, accumulation and cellular sequestration in plants. More specifically, the methods of the invention comprise modifying plant cells that express farnesene to convert the farnesene to farnesol, and in some cases, to farnesol glycoside, such as farnesol glucoside. In other... Agent: Chromatin, Inc.

20140249302 - Methods for making and using molecular switches involving circular permutation: The invention provides molecular switches which couple external signals to functionality, and combinatorial methods of making and using the same involving circular permutation of nucleic acid and amino acid sequences. The switches according to the invention can be used, for example, to regulate gene transcription, target drug delivery to specific... Agent: The Johns Hopkins University

20140249303 - Methods for detecting a polymorphism in the nfkb1 gene promoter: The present invention discloses a functional relationship between a recognized disease condition and a polymorphism in the nucleotide factor kappa B promoter (NFKB1). This relationship provides a platform for methods of altering promoter activity and for determining similar relationships between specific pathologies and identified polymorphisms. A statistically significant risk of... Agent: The Johns Hopkins University

20140249304 - Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes: A long interfering dsRNA (liRNA) capable of inhibiting specific RNAi-mediated expression of target genes and promoting an immune reaction, and use thereof are provided. The long interfering dsRNA can be useful in inhibiting specific expression of target genes through an RNA-interfering reaction in a sequence-specific manner and inducing expression of... Agent: Research & Business Foundation Sungkyunkwan University

20140249305 - Method for producing hydrophilic cellulose fiber: The present invention relate to a hydrophilized cellulose fiber producing method, comprising the steps of: (1a) oxidizing cellulose fibers in a reaction solution containing a N-oxyl compound, an oxidizing agent, and sodium sulfate to provide oxidized cellulose fibers; and (1b) separating the obtained oxidized cellulose fibers from the reaction solution,... Agent: Gunze Limited

08/28/2014 > 7 patent applications in 6 patent subcategories.

20140243512 - Sorbent comprising an aromatic ring system on its surface for the purification of organic molecules: In a first embodiment the present invention relates to a sorbent comprising a porous inorganic solid support material having on its surface a film of a crosslinked polyvinylamine comprising derivatized amine groups and amine groups binding to the surface of the support material via electron donor/acceptor interactions. In a second... Agent: Instraction Gmbh

20140243513 - Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla): Also herein is disclosed a method of extracting lipopolysaccharide (LPS) from a culture of deep rough mutant bacterial strain cells, comprising: (a) extracting the cells with a solution consisting essentially of at least about 75 wt % of an aliphatic alcohol having from 1 to 4 carbon atoms and the... Agent: Glaxosmithkline Biologicals S.a.

20140243514 - Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin: The invention relates to the use of adsorb/desorb chromatography to prepare enriched compositions comprising rebaudioside B and/or rebaudioside D. Compositions with enriched rebaudioside-B and/or rebaudioside-D components may be prepared from Stevia-derived glycoside compositions using an adsorb-desorb chromatography process where the stationary phase of the chromatography bed comprises a macroporous neutral... Agent: Cargill, Incorporated

20140243515 - Antisense oligonucleotides for inducing exon skipping and methods of use thereof: An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 202.... Agent: The University Of Western Australia

20140243516 - Antisense oligonucleotides for inducing exon skipping and methods of use thereof: An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 202.... Agent: The University Of Western Australia

20140243517 - Methods of producing c-aryl glucoside sglt2 inhibitors: Method for the production of C-aryl glucoside SGLT2 inhibitors useful for the treatment of diabetes and related diseases. and intermediates thereof. The C-aryl glucosides may be complexed with amino acid complex forming reagents.... Agent: Astrazeneca Ab

20140243518 - Method for preparing cationic galactomannans: t

08/21/2014 > 13 patent applications in 10 patent subcategories.

20140235839 - Process for producing novel sialo-sugar chain: The present invention provides a novel sialo-sugar chain, a process for producing the sialo-sugar chain, and a device for producing the sialo-sugar chain. A sialo-sugar chain can be easily and efficiently mass-produced by reacting a sugar wherein a hydroxy groups is substituted with an alkynyl group (herein sometimes referred to... Agent:

20140235840 - New synthesis of fucose: A process for converting D-glucose into L-fucose, where a first aspect of the disclosure relates to a method of making a compound of formula (1) wherein R is independently H, alkyl or phenyl or, preferably, wherein the two germinal R groups together with the carbon atom to which they are... Agent:

20140235842 - Convenient and efficient purification method for chemically labeled nucleic acids: In particular, the present invention relates to a convenient method for purifying labeled nucleic acids in a fast manner with high efficiency from a mixture of unreacted hydrophobic chemical probes, unreacted nucleic acids and labeled nucleic acids, comprising the steps of reacting hydrophobic chemical probe and nucleic acids in an... Agent: Snu R&db Foundation

20140235841 - Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity: The invention relates to our discovery of a novel double-stranded ribonucleic acid (dsRNA) having specific biological activities, which includes acting as a selective agonist for activation of the Toll-like receptor 3. Its “rugged” molecular structure as measured by physico-chemical techniques is resistant to molecular unfolding (i.e., denaturation). This structure appears... Agent: Hemispherx Biopharma, Inc.

20140235843 - Antibodies to cd70: The present invention relates to antibodies and antigen binding fragments thereof which bind to the human CD70 protein with high affinity and display potent inhibition of tumour cell growth.... Agent: Argen-x B.v.

20140235845 - Sequence amplification with loopable primers: The present disclosure relates to the amplification of target nucleic acid sequences. This can be accomplished via the use of various primers. The use of these primers, as described herein, results in nucleic acid structures that can reduce the amplification of nonspecific hybridization events (such as primer dimerization) while allowing... Agent: Life Technologies Corporation

20140235844 - Short interfering rna (sirna) analogues: The present invention is directed to novel double-stranded short interfering (siRNA) analogues comprising locked nucleic acid (LNA) monomers. Such compounds induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as RNA interference (RNAi). The compounds disclosed herein has improved properties compared to non-modified siRNAs and may, accordingly,... Agent: Santaris Pharma A/s

20140235847 - Methods, compositions, and kits for generating rrna-depleted samples or isolating rrna from samples: The present invention provides methods, compositions, and kits for generating rRNA-depleted samples and for isolating rRNA from samples. In particular, the present invention provides compositions comprising affinity-tagged antisense rRNA molecules corresponding to substantially all of at least one rRNA molecule (e.g., 28S, 26S, 25S, 18S, 5.8S and 5S eukaryotic cytoplasmic... Agent: Epicentre Technologies Corporation

20140235846 - Polyelectrolyte-coated ion-exchange particles: A polyelectrolyte-coated particle, devices for using the particle, methods for using the particle for separating PCR reaction products and/or DNA sequencing reaction products, and compositions for coating the particle are provided.... Agent: Applied Biosystems, LLC

20140235848 - Method for making a precursor of l-fucose from d-glucose: A method that can be used to make a precursor of L-fucose from D-glucose that includes the steps of a) making a compound of formula (1) from D-glucose, formula (1) wherein R1 is acyloxy, and Q is a group (a), (b), (c) or (d), formula (a), (b), (c) or (d)... Agent: Glycom A/s

20140235849 - Method for increasing the yield in lactose production (iii): m

20140235850 - Synthesis of hmo core structures: The invention relates to a method for making precursors of HMO core structures comprising a step of reacting an N-acetyllactosamine or lacto-N-biose derivative donor with a lactose or N-acetyllactosamine derivative acceptor, wherein the donor is an oxazoline donor.... Agent:

20140235851 - Chemical transformation of lignocellulosic biomass into fuels and chemicals: A method for converting a carbohydrate to a furan in a polar aprotic solvent in the presence of a chloride, bromide, or iodide salt or a mixture thereof and optionally in the presence of an acid catalyst, a metal halide catalyst and/or an ionic liquid (up to 40 wt %).... Agent: Wisconsin Alumni Research Foundation

08/14/2014 > 6 patent applications in 5 patent subcategories.

20140228554 - Synthesis of new fucose-containing carbohydrate derivatives: A method for the synthesis of a fucooligosaccharide glycosides by reacting a fucosyl donor with H-A-R1 or a salt thereof, wherein A and R1 are as defined herein, under the catalysis of an enzyme capable of transferring fucose is provided. The fucooligosaccharid glycoside compounds, or derivatives thereof, their use in... Agent: Glycom A/s

20140228555 - Preparation process of erythromycin thiocyanate: Disclosed is a preparation process of erythromycin thiocyanate, which belongs to the pharmaceutical field. The preparation process provided by the invention uses erythromycin or its salt(s) as raw material(s), dissolves it/them in acetone or the mixed solvent containing acetone and obtains erythromycin thiocyanate rich in erythromycin thiocyanate A as the... Agent: Hec Pharm Co., Ltd

20140228557 - Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9): Antigen binding proteins that interact with Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) are described. Methods of treating hypercholesterolemia and other disorders by administering a pharmaceutically effective amount of an antigen binding protein to PCSK9 are described. Methods of detecting the amount of PCSK9 in a sample using an antigen... Agent: Amgen, Inc.

20140228556 - Ribozyme for identifying modification on rna sequence and rna cleavage method using same: The hammerhead ribozyme according to the present invention produces a hammerhead ribozyme—target RNA construct by base-pairing with an edited target RNA, and an editing recognition site of the hammerhead ribozyme cleaves the modification site by forming a base pair with the target RNA modification site. The cleavage of the modification... Agent: Fukuoka University

20140228558 - Method and device for optimizing a nucelotide sequence for the purpose of expression in a protein: The invention relates to a method for optimizing a nucleotide sequence for expression of a protein on the basis of the amino acid sequence of the protein, in which for a particular region there is specification of a test sequence with m optimization positions on which the codon occupation is... Agent: Geneart Ag

20140228559 - Dissolution of oxidized cellulose: A process for dissolving modified cellulose is disclosed. The process includes contacting modified cellulose with a solvent in a mixture to form swelled modified cellulose and then contacting the mixture with a salt to dissolve the swelled modified cellulose.... Agent:

Previous industry: Organic compounds -- part of the class 532-570 series
Next industry: Organic compounds -- part of the class 532-570 series


RSS FEED for 20140904: xml
Integrate into your RSS reader/aggregator or website to track weekly updates.
For more info, read this article.


Thank you for viewing Organic compounds -- part of the class 532-570 series patents on the website. These are patent applications which have been filed in the United States. There are a variety ways to browse Organic compounds -- part of the class 532-570 series patent applications on our website including browsing by date, agent, inventor, and industry. If you are interested in receiving occasional emails regarding Organic compounds -- part of the class 532-570 series patents we recommend signing up for free keyword monitoring by email.

Results in 0.16091 seconds